1. Home
  2. LBRDA vs RGEN Comparison

LBRDA vs RGEN Comparison

Compare LBRDA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation

LBRDA

Liberty Broadband Corporation

HOLD

Current Price

$52.63

Market Cap

7.3B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$122.23

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDA
RGEN
Founded
2014
1981
Country
United States
United States
Employees
1900
N/A
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
LBRDA
RGEN
Price
$52.63
$122.23
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$172.91
AVG Volume (30 Days)
150.0K
768.4K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
N/A
$14.30
Revenue Next Year
$109.28
$14.52
P/E Ratio
$8.39
$139.72
Revenue Growth
N/A
35.10
52 Week Low
$42.05
$109.66
52 Week High
$100.85
$175.77

Technical Indicators

Market Signals
Indicator
LBRDA
RGEN
Relative Strength Index (RSI) 57.34 53.95
Support Level $51.95 $121.25
Resistance Level $55.15 $130.56
Average True Range (ATR) 1.73 4.59
MACD 0.22 1.72
Stochastic Oscillator 97.13 98.50

Price Performance

Historical Comparison
LBRDA
RGEN

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: